tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BIIB Stock Latest News

Biogen highlights ‘promising’ results for higher-dose nusinersen in SMA trials
The FlyBiogen highlights ‘promising’ results for higher-dose nusinersen in SMA trials
1d ago
BIIB
Biogen’s New Study on Omaveloxolone: Implications for Investors
PremiumCompany Announcements
Biogen’s New Study on Omaveloxolone: Implications for Investors
2d ago
BIIB
Salanersen presents long-term upside opportunity for Biogen, says Morgan Stanley
PremiumThe Fly
Salanersen presents long-term upside opportunity for Biogen, says Morgan Stanley
3d ago
BIIB
Biogen price target raised to $213 from $205 at RBC Capital
PremiumThe Fly
Biogen price target raised to $213 from $205 at RBC Capital
3d ago
BIIB
Ionis Pharmaceuticals partner Biogen announces results from salanersen study
PremiumThe Fly
Ionis Pharmaceuticals partner Biogen announces results from salanersen study
3d ago
BIIB
IONS
Biogen announces topline results from Phase 1 study of salanersen
PremiumThe FlyBiogen announces topline results from Phase 1 study of salanersen
3d ago
BIIB
Biogen Elects Board and Ratifies Auditor at Meeting
Premium
Company Announcements
Biogen Elects Board and Ratifies Auditor at Meeting
5d ago
8K
BIIB
Biogen initiates Phase 3 pediatric study of omaveloxolone
Premium
The Fly
Biogen initiates Phase 3 pediatric study of omaveloxolone
10d ago
BIIB
H.C. Wainwright sees potential competition for Sage from Biogen
PremiumThe Fly
H.C. Wainwright sees potential competition for Sage from Biogen
11d ago
BIIB
SAGE
Biogen’s Strategic Diversification and Promising Pipeline Drive Buy Rating
PremiumRatings
Biogen’s Strategic Diversification and Promising Pipeline Drive Buy Rating
11d ago
BIIB
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
11d ago
BIIB
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
PremiumThe Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
11d ago
BIIB
SAGE
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
PremiumThe FlySupernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
12d ago
BIIB
SAGE
Jefferies sees Akero, Scholar Rock as ‘promising’ takeover targets
Premium
The Fly
Jefferies sees Akero, Scholar Rock as ‘promising’ takeover targets
15d ago
LLY
MRK
Biogen’s Felzartamab: A Promising Blockbuster Potential in Antibody-Mediated Conditions
Premium
Ratings
Biogen’s Felzartamab: A Promising Blockbuster Potential in Antibody-Mediated Conditions
16d ago
BIIB
Biogen’s Long-Term Potential Overshadowed by Near-Term Challenges: Hold Rating Justified
PremiumRatings
Biogen’s Long-Term Potential Overshadowed by Near-Term Challenges: Hold Rating Justified
16d ago
BIIB
Biogen, UCB present results from Phase 3 PHOENYCS GO study of DZP
PremiumThe Fly
Biogen, UCB present results from Phase 3 PHOENYCS GO study of DZP
17d ago
BIIB
Biogen’s Hold Rating: Navigating Opportunities and Challenges in Clinical Developments
PremiumRatings
Biogen’s Hold Rating: Navigating Opportunities and Challenges in Clinical Developments
17d ago
BIIB
Biogen presents additional results from PHOENYCS GO study
PremiumThe Fly
Biogen presents additional results from PHOENYCS GO study
17d ago
BIIB
Biogen’s Strategic Advancements in Autoimmune Sector Drive Buy Rating
PremiumRatingsBiogen’s Strategic Advancements in Autoimmune Sector Drive Buy Rating
17d ago
BIIB
Biogen highlights potential of felzartamab
Premium
The Fly
Biogen highlights potential of felzartamab
17d ago
BIIB
Biogen’s Strategic Growth and Diversification Drive Buy Rating
Premium
Ratings
Biogen’s Strategic Growth and Diversification Drive Buy Rating
17d ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >